A new methodology for the prevention of pancreatic cancer – one of the most deadly cancers – develops in Greek workshops. The reason for the ongoing research in National Institute of Research and in Aretaeio Hospitalwith the support of Bodosak Foundationor, in which the diagnosis of deck cancer can be achieved by blood test and DNA analysis.

This is the resolution of a serious medical puzzle. “The pancreas cancer has a very bad prognosis and the only hope for patients is to make the diagnosis in a timely manner so that they can be operated before it gives metastases. ” tells to Everyday Professor of Surgery – Endoscopic Surgery Antonis Vezakis. However, today only 25% of cases are surgical, as either cancer has already made metastases or it is so extensive locally that it cannot be operated on. The delay in diagnosis is critical. “An important problem is that pancreas cancer has no particular symptoms. Your waist or stomach may hurt you and not evaluate pain as something serious. “

High -risk groups belong to patients who have been diagnosed with pancreatic cysts, who have genetic predisposition and patients with chronic pancreatitis. The diagnosis of pancreatic cysts is made by various imaging methods. These methods, however, cannot distinguish between benign and malignant cysts. As the Director of the National Research Foundation explains, Demosthenes Sarrigiannisto date this can only be determined by surgical resection.

Pancreatic cysts are very common. “Of those undergoing magnetic resonance imaging, 5% -15% have cysts in the pancreas. Of these, 1% -2% will develop into cancer ‘, says Mr. Vezakis. The bet for scientists is to be able to distinguish which of those who are diagnosed with cysts in the pancreas are suspected of developing cancer. It is obvious that a non -invasive diagnostic method would solve the hands of doctors and save lives.